These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7570761)

  • 1. Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke.
    Lalouschek W; Suess E; Aull S; Schnider P; Uhl F; Zeiler K; Pabinger-Fasching I
    Stroke; 1995 Oct; 26(10):1963-4. PubMed ID: 7570761
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V Leiden mutation and completed stroke.
    Catto A; Carter A; Grant PJ
    Stroke; 1996 Mar; 27(3):573. PubMed ID: 8610336
    [No Abstract]   [Full Text] [Related]  

  • 3. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.
    Lalouschek W; Aull S; Serles W; Schnider P; Mannhalter C; Pabinger-Fasching I; Deecke L; Zeiler K
    Thromb Res; 1999 Jan; 93(2):61-9. PubMed ID: 9950259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family].
    Moia M; La Spina I; Padalino R; Carpenedo M
    Ann Ital Med Int; 1996; 11(1):17-9. PubMed ID: 8645525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance due to a factor V mutation associated with familial ischemic stroke.
    De Lucia D; Nina P; Papa ML; Belli A; Conte M; Renis V; Di Mauro C; Masi S; Franco A; Schisano G
    J Neurosurg Sci; 1997 Dec; 41(4):373-8. PubMed ID: 9555645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke in a neonate heterozygous for factor V Leiden.
    Varelas PN; Sleight BJ; Rinder HM; Sze G; Ment LR
    Pediatr Neurol; 1998 Mar; 18(3):262-4. PubMed ID: 9568926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.
    Fisher M; Fernandez JA; Ameriso SF; Xie D; Gruber A; Paganini-Hill A; Griffin JH
    Stroke; 1996 Jul; 27(7):1163-6. PubMed ID: 8685921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C.
    Press RD; Liu XY; Beamer N; Coull BM
    Stroke; 1996 Jan; 27(1):44-8. PubMed ID: 8553401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden: a case study and review.
    Slusher KB
    Dimens Crit Care Nurs; 2010; 29(1):6-10. PubMed ID: 20010186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
    Cushman M; Rosendaal FR; Psaty BM; Cook EF; Valliere J; Kuller LH; Tracy RP
    Thromb Haemost; 1998 May; 79(5):912-5. PubMed ID: 9609219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden mutation in cerebrovascular disease.
    Buyru N; Altinisik J; Somay G; Ulutin T
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):339-42. PubMed ID: 16015421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome].
    Kalashnikova LA; Dobrynina LA; Patrusheva NL; Kovalenko TF; Patrushev LI; Aleksandrova EN; Berkovskiĭ AL; Sergeeva EV; Nasonov EL
    Ter Arkh; 2005; 77(10):49-53. PubMed ID: 16320685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
    Thorarensen O; Ryan S; Hunter J; Younkin DP
    Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral apoplexy--anticardiolipin antibody and factor V Leiden mutation].
    Kirkeby R; Pedersen OD
    Ugeskr Laeger; 1997 Apr; 159(15):2233-5. PubMed ID: 9148550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2009 Dec; 34(8):e811-3. PubMed ID: 19793098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary antiphospholipid syndrome and factor V Leiden mutation in a young patient with non-bacterial thrombotic endocarditis and transient ischemic stroke.
    Letsas KP; Filippatos GS; Kounas SP; Pappas LK; Gavrielatos G; Kardaras F
    Thromb Haemost; 2005 Dec; 94(6):1331-2. PubMed ID: 16411415
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
    Hirmerova J; Seidlerova J; Subrt I
    QJM; 2014 Sep; 107(9):715-20. PubMed ID: 24633260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are your clients at risk? Factor V Leiden, clotting, and pregnancy.
    Rosenberg J
    Midwifery Today Int Midwife; 2000; (55):43-4, 69. PubMed ID: 11189567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.